Clinical trial
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic…
NCT00199004 · Johann Wolfgang Goethe University Hospital, Other · Completed
Key facts
| NCT number | NCT00199004 |
|---|---|
| Title | Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab |
| Official title | German Multicenter Trial for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years With Rituximab for Improvement of Prognosis in CD20 Positive Standard Risk ALL (Amend 2) |
| Lead sponsor | Johann Wolfgang Goethe University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Adult Acute Lymphocytic Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, Dexamethasone / Prednisolone, Vincristine, Daunorubicin, Asparaginase, Methotrexate, Cytarabine, Mercaptopurine, G-CSF, Vindesine and 8 more |
| Enrollment | 60 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 23, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: